Please login to the form below
Coronavirus disruption scuppers Curium Pharma sale
London-based private equity firm CapVest will wait for market to improve
Did Trump offer CureVac $1bn for COVID-19 vaccine rights?
Media reports claim Trump administration tried to secure exclusive rights
Lilly joins new Medicare scheme to reduce insulin prices
New model will cover seniors enrolled in Medicare Part D
Shionogi makes buyout play for Tetra ahead of Alzheimer’s readout
Pivotal mid-stage trial results due later this month
AbbVie says Allergan takeover delayed by FTC verdict
Merger now likely to complete in second quarter rather than first
Gilead swoops on Forty Seven with $4.9bn all-cash deal
Takeover is latest in a string of billion-plus deals signed by Gilead
Boehringer links up with Trutino for cancer R&D
Collaboration agreement will focus on cytokine treatments
Biogen bulks up in Alzheimer’s again with $2.7bn Sangamo deal
Gains rights to tau-targeting drug ST-501 as part of broader alliance
Takeda buys coeliac disease partner PvP Biologics after phase 1 win
Deal includes upfront payment plus up to $330m in milestones
Health coverage across state lines
Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad
-
Standing out in a crowdCelltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars
-
The diseased organisationLike humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured
-
Tocagen merges with Forte Biosciences after brain cancer fail New company will focus on Forte's lead skin disease drug
-
GSK pays $50m upfront to tap Immatics’ cell therapy platformDeal focuses on T cell receptor therapies
-
Merck KGaA divests allergy business to DermapharmThe sum of the agreement remains undisclosed
-
Bluebird bio leans on pipeline and Zynteglo launch as revenues fall Revenues down from last year but beat analyst expectations
-
AZ revenues rise, but it says coronavirus could hit 2020Product sales up 12% to $23.57bn for the full-year
-
Revenue growth at Ipsen numbs pain of palovarotene calamityFrench speciality drugmaker posted €2.58bn sales for the full-year
-
Botox strength bolsters Allergan ahead of AbbVie takeoverSpeciality drugmaker posted a 6.6% sales increase in the last quarter
-
New hires at Ferring, Flexion and Immunocore The latest movers in pharma
-
New hires at Nanoform, Leo Pharma and CalliditasThe latest movers in pharma and biotech
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMOLatest movers in pharma and biotech
-
New hires at Mundipharma, Sinclair Pharma and Relay TherapeuticsLatest movers in pharma
-
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership teamThe latest industry movers
Latest sales appointments
COVID-19 Updates and Daily News
Featured jobs
- Sinovac reveals positive preliminary data for COVID-19 vaccine
- How will the events and exhibitions industry change post-Coronavirus?
- Finalists 2020 - Communiqué Awards
- Novo Nordisk gets another OK for oral GLP-1 drug Rybelsus
- Novo Nordisk gets another OK for oral GLP-1 drug Rybelsus
- The best work in healthcare communications shines at virtual Communiqué Awards
PMHub
SEVEN STONES
Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....
Latest intelligence
- The search for treatments for Parkinson’s disease
- The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
- Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
- Ditch the Label – it’s just me....
- The impact of COVID-19 on clinical trials
- As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...
Quick links
Infographics
